Zealand Pharma A/S

Zealand Pharma A/S is a Danish biotechnology company that focuses on the discovery, development, and commercialization of peptide-based medicines. As a biopharmaceutical firm, Zealand Pharma's core purpose is to deliver innovative therapies that address unmet medical needs in various fields such as metabolic and gastrointestinal diseases. The company is recognized for its strong expertise in peptide research and has developed a robust R&D pipeline featuring novel therapeutic approaches. Situated in an industry that is highly competitive and research-intensive, Zealand Pharma collaborates extensively with global partners to enhance its scientific efforts and commercialization strategies. By consistently advancing its clinical programs and fostering strategic alliances, Zealand Pharma plays a significant role in the biotechnology sector, contributing to advancements in peptide therapeutics and healthcare solutions globally. Founded in 1998 and headquartered in Copenhagen, Zealand Pharma continues to leverage its specialized knowledge in peptides to expand its influence and capacity within the biopharma market.